Perspectum Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Perspectum Diagnostics's estimated annual revenue is currently $116.7M per year.
- Perspectum Diagnostics's estimated revenue per employee is $351,400
- Perspectum Diagnostics's total funding is $64.2M.
Employee Data
- Perspectum Diagnostics has 332 Employees.
- Perspectum Diagnostics grew their employee count by 1% last year.
Perspectum Diagnostics's People
| Name | Title | Email/Phone |
|---|
Perspectum Diagnostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Perspectum Diagnostics?
Perspectum Diagnostics is dedicated to the creation of safe, non-invasive alternatives to traditional abdominal testing methods. Our first product, LiverMultiScan is FDA-cleared and available for clinical use in Europe and the USA and Australia. Our research tool, LiverMultiScan Discover, is currently supporting both clinical and preclinical trials, detecting change in as little as four weeks.
keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals
$64.2M
Total Funding
332
Number of Employees
$116.7M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Perspectum Diagnostics News
Perspectum; Illumina, Inc.; Koninklijke Philips N.V.; GE Healthcare; Siemens Healthineers AG; QIAGEN; and F. HOFFMANN-LA ROCHE LTD have...
AI.Reverie raised $5.6M; Atlas AI landed $7M; Nelumbo secured $14M; Perspectum picks up $36M AI.Reverie: AI.Reverie is a simulation platform that's trying to generate synthetic data to train airport simulation, weapons detection, cashier-less shopping and delivery bot algorithms, among other pr ...
Perspectum, an Oxford, UK-based medical software company that provides non-invasive technology for identifying and monitoring multiple diseases, completed a $36M financing. The round was co-led by the Blue Venture Fund and HealthQuest Capital, with participation from Oxford Science Innovation, ...
... Algernon Pharmaceuticals, Celerion, NuSirt Biopharma, Perspectum Diagnostics., Boehringer Ingelheim International GmbH and others.
“Perspectum Diagnostics shares our commitment to best in class quality built on a foundation of patient focus. We feel that Perspectum ...
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $61.3M | 338 | 6% | N/A |
#2 | $105.2M | 342 | N/A | N/A |
#3 | $57M | 345 | -5% | N/A |
#4 | $81.7M | 363 | N/A | N/A |
#5 | $76.7M | 372 | 21% | N/A |